BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6415312)

  • 1. [Analysis of factors affecting clinical cancer chemotherapy].
    Wakui A; Taguchi T
    Gan No Rinsho; 1983 Aug; 29(10):1199-204. PubMed ID: 6415312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).
    Bitran JD; Desser RK; Kozloff MF; Billings AA; Shapiro CM
    Cancer Treat Rep; 1979; 63(11-12):2049-51. PubMed ID: 393388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy of pancreatic cancer].
    Yoshimori M; Tajiri H; Nakamura K; Ozaki H
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):227-34. PubMed ID: 3155930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinicopathological study on preoperative anticancer chemotherapy for gastric cancer (author's transl)].
    Honda H
    Nihon Geka Hokan; 1978 May; 47(3):333-63. PubMed ID: 354546
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental chemotherapy of human gastrointestinal and breast cancers in nude mice and its correlation to clinical effect].
    Fujita M; Fujita F; Taguchi T
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1168-74. PubMed ID: 6433068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer.
    Smith FP; Rustgi VK; Schertz G; Woolley PV; Schein PS
    Cancer Treat Rep; 1982 Dec; 66(12):2095-6. PubMed ID: 6215982
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy of stomach cancer].
    Gropp C; Havemann K
    Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
    Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M; Koga S; Hashimoto I; Kondo T; Fujimoto S; Sugiyama Y; Abe O; Ohya M
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2133-47. PubMed ID: 6820890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Single chemotherapy with 5-fluorouracil or ftorafur and combination chemotherapy with mitomycin C and 5-fluorouracil for inoperable elderly gastric cancers].
    Fujii M; Murakami N
    Nihon Gan Chiryo Gakkai Shi; 1983 Feb; 18(1):1-4. PubMed ID: 6408206
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of Borrmann's type IV diffuse carcinoma of the stomach].
    Suga S; Kimura K; Yokoyama Y
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2478-84. PubMed ID: 6418076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin (Mutamycin).
    Med Lett Drugs Ther; 1975 Jul; 17(15):62-3. PubMed ID: 50555
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.
    Kelsen D
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):58-66. PubMed ID: 8091242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy of pancreatic cancer is not yet generally recommended].
    Hartwich G
    Med Klin; 1980 Aug; 75(16):575-9. PubMed ID: 6447832
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of various antineoplastic agents combined with urokinase--a comparison between urokinase from tissue culture (TCUK) and urine-derived urokinase (UUK)].
    Yamamoto M
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1461-73. PubMed ID: 6820918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies of cancer chemotherapy combined with angiotensin-II (ANG-II)].
    Takahashi N; Kunii Y; Kanno H; Kikuchi K
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1640-5. PubMed ID: 6820924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined application of drugs in cancer chemotherapy with special reference to the combination of mitomycin C, 5-fluorouracil, and cytosine arabinoside].
    Nakao I; Furue H; Furukawa K; Kanko T; Harashima S
    Gan No Rinsho; 1972 Feb; 18(2):138-43. PubMed ID: 5063156
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy of stomach cancer].
    Omuraliev A
    Vopr Onkol; 1980; 26(5):89-99. PubMed ID: 6770542
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of advanced gastric cancer which disappeared histopathologically after short-time chemotherapy].
    Hara K; Yokoyama T; Furuta K; Shinoda M; Yajima K; Yasuda S; Nakazaki S; Kiyomitsu Y; Watanabe K
    Gan No Rinsho; 1984 Apr; 30(4):399-402. PubMed ID: 6727041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience of a combination chemotherapy consisting of 5-FU, MMC, and FT-207--side effects against kidney].
    Yamada F; Kagami H; Fukutome A; Mastumine T; Miura T
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2049-54. PubMed ID: 6412636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.